次世代シーケンサー市場：セグメント別規模、シェア、法規制、償還、設置ベース、2033年までの予測

次世代シーケンサーは、DNAまたはRNAの塩基配列を迅速かつ効率的に決定するために使用される機器です。次世代シーケンサーは、1回のシーケンシングあたりの効率的なスループットを提供し、超並列処理が可能で、遺伝的変異の解明、複雑な疾患の理解、がんゲノミクス、微生物学、進化生物学などの分野における研究の進展に役立っています。

治療方針の個別化のために多数の変異を検査することは今や標準的なことであり、標的となりうる幅広い変異について腫瘍生検を評価できる次世代シーケンサーの使用が増加しています。

当レポートは、世界の次世代シーケンサー市場について詳細に考察し、市場における競合情勢、SWOT分析、2033年までの市場予測、地域、国別の動向などを提供しています。

目次

現在上市されている次世代シーケンサーと競合情勢

• 主要な業界動向の洞察
• 次世代シーケンサーのセグメント別総市場収益と2015年～2033年の市場展望
• 台数、平均販売価格、市場価値に関する詳細データ

世界、地域、国別の洞察

• 次世代シーケンサー市場のSWOT分析
• 次世代シーケンサー市場に関する競合力学の洞察と動向
• 国別の医療制度の概要
• 国別の償還政策
• 国別の医療技術に関する規制の状況

Next Generation Sequencers Market Size by Segments, Share, Regulatory, Reimbursement, Installed Base and Forecast to 2033 is built to visualize quantitative and qualitative market trends within In Vitro Diagnostics therapeutic area.

Next-generation sequencers are instruments used to determine the nucleotide sequence of DNA or RNA rapidly and efficiently. Offering an efficient throughput per sequencing, next-generation sequencers are capable of massively parallel processing and are instrumental in uncovering genetic variations, understanding complex diseases, and advancing research in areas such as cancer genomics, microbiology, and evolutionary biology.

The next-generation sequencers track the essential equipment only, and not accessories and/or additional costs associated with next-generation sequencer installation.

It is now standard to test for a high number of mutations to personalize treatment decisions, use of Next Generation Sequencers that can evaluate tumor biopsies for a wide range of potentially targetable mutations is increasing.

Each of the covered 39 countries color-coded and fully-sourced market models are equipped with installed base. The interactive excel deliverable covers value, volumes, product usage, average selling prices, market size and company share/rank analysis (wherever available). Moreover, analyst comments with qualitative insights offer context for quantitative data.

Key Inclusions of the market model are:

Currently marketed Next Generation Sequencers and evolving competitive landscape:

• Insightful review of the key industry trends.
• Annualized total Next Generation Sequencers market revenue by segment and market outlooks from

2015- 2033

• Market level data on units, average selling prices and market values.

Global, Regional and Country level market specific insights:

• Qualitative market specific information is available with global trends further broken down into regional trends. In addition, GlobalData analysts provide unique country specific insights on the market.
• SWOT analysis for Next Generation Sequencers market.
• Competitive dynamics insights and trends provided for Next Generation Sequencers market.

Drive the understanding of the market by getting the veritable big picture including an overview of the healthcare system. In addition, the Market Access segment allows you to delve deeper into market dynamics with information on reimbursement policies and the regulatory landscape.

• Country specific overview of the healthcare system.
• Country specific reimbursement policies.
• Country specific medtech regulatory landscape.

.

Robust methodologies and sources enable the model to provide extensive and accurate overview of the market. Demand and supply-side primary sources are integrated within the syndicated models, including Key Opinion Leaders. In addition, real world data sources are leveraged to determine market trends; these include government procedure databases, hospital purchasing databases, and proprietary online databases.

Companies covered: Illumina Inc, Pacific Biosciences, Thermo Fisher Scientific Inc, Singular Genomics System Inc , and others.

Countries covered: United States, United Kingdom, Germany, France, Italy, Spain, Brazil, China, India, Russia, Japan, Australia, Canada, Mexico, South Korea, Denmark, Ireland, Netherlands, New Zealand, South Africa, Sweden, Switzerland, Austria, Belgium, Finland, Israel, Norway, Poland, Portugal, Taiwan, Czech Republic, Greece, Hungary, Turkey, Egypt, Saudi Arabia, United Arab Emirates, Argentina and Chile.

Scope

This Market Model gives important, expert insight you won't find in any other source. The model illustrates qualitative and quantitative trends within the specified market. This model is required reading for -

• CMO executives who must have deep understanding of the Next Generation Sequencers market place to make strategic planning and investment decisions.
• Sourcing and procurement executives who must understand crucial components of the supply base in order to make decisions about supplier selection and management.
• Private equity investors that need a deeper understanding of the market to identify and value potential investment targets.

Reasons to Buy

The model will enable you to -

• Develop and design your in-licensing and out-licensing strategies through a review of pipeline products, by identifying key companies.
• Develop business strategies by understanding the trends shaping and driving Next Generation Sequencers market.
• Drive revenues by understanding the key trends, innovative products and technologies, market segments, and companies likely to impact the Next Generation Sequencers market in the future.
• Formulate effective sales and marketing strategies by understanding the competitive landscape and by analyzing the company share of market leaders.
• Identify emerging players with potentially strong product portfolios and create effective counterstrategies to gain a competitive advantage.
• Track device sales in the global and country-specific Next Generation Sequencers market from 2015-2033.
• Organize your sales and marketing efforts by identifying the market categories and segments that present maximum opportunities for consolidations, investments, and strategic partnerships.